Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Arrive AI Inc. closed a $250,000 private placement (PIPE) with an accredited investor, issuing 384,615 shares of common stock and warrants at a purchase price of $0.65 per unit. The investment was priced at a 213% premium to the company's recent trading price, and the investor expressed interest in evaluating up to $10 million in additional future financing.
Artelo Biosciences was identified as one of approximately 180 companies currently below Nasdaq's new $5 million minimum Market Value of Listed Securities (MVLS) requirement. While the rule is currently under a temporary stay and subject to proposed modifications, the company is monitoring the situation and considering potential actions to maintain compliance, such as capital raises or expense management.
Live Nation reports record demand with double-digit fan growth expected for 2026, driven by international expansion and a strong second-half concert slate.
Vivakor Signs $40M M&A Deal with Direct Midstream, LLC
Vivakor, Inc. has signed a non-binding Letter of Intent to acquire 100% of Direct Midstream, LLC for a gross purchase price of $40 million. The deal structure includes a $10 million capital investment by Vivakor, with the remaining consideration consisting of $29 million in Series B Preferred Stock and $1 million in common stock. The acquisition aims to expand Vivakor's Permian Basin infrastructure and oilfield waste management capabilities.
Crescent Energy Company priced an underwritten public offering of 80,000,000 shares of Class A Common Stock at $12.50 per share, with underwriters fully exercising their option for an additional 12,000,000 shares. The company expects to receive approximately $1,115.9 million in net proceeds, which will be used to fund the cash consideration for its acquisition of Eagle Ford assets from Devon Energy. KKR & Co. Inc. affiliates participated in the offering by purchasing 40,000,000 shares at the public offering price.
SINTX Technologies received approximately $2.01 million in gross proceeds from the exercise of Class B Common Stock Purchase Warrants. The company issued 651,204 shares of common stock and 290,219 pre-funded warrants at an exercise price of $2.14 per share, while unexercised Class B warrants expired.
DarkPulse, Inc. received notice that its common stock was removed from the OTCQB market and moved to the OTCID market effective October 8, 2026. The transition occurred because the company failed to maintain the minimum bid price requirement of $0.01 per share following the expiration of a grace period.
Selectis Health M&A Deal with Black Pearl Equities II, LLC
Selectis Health, Inc. completed its merger with Black Pearl Equities II, LLC, a subsidiary of Black Pearl Equities, LLC. Following a successful tender offer for approximately 90.93% of outstanding shares at $5.75 per share, the company merged with a subsidiary of the purchaser and became a wholly owned private subsidiary. The merger was effected under Utah law without a stockholder vote.
iSpecimen Inc. stockholders approved the acquisition of assets from Foldlab AI Ltd., which includes the issuance of common stock as partial consideration. The company also received approval for potential future equity issuances exceeding 19.99% of outstanding shares under Nasdaq rules, while the vote on a proposed reverse stock split was adjourned to October 30, 2026.
bioAffinity Technologies entered into a securities purchase agreement with an institutional investor to raise approximately $4 million in gross proceeds. The offering consists of 116,545 shares of common stock and pre-funded warrants for 536,836 shares, priced at $6.122 and $6.115 respectively, alongside a private placement of unregistered warrants.
XMax Signs $4.12M M&A Deal with Hexa Creation Inc.
XMax Inc. entered into a definitive agreement to acquire 100% of Hexa Creation Inc. for approximately $4.12 million in cash. Hexa Creation is a developer of 1200V vertical gallium nitride (GaN) power semiconductor technology aimed at AI data center infrastructure. The deal expands XMax's strategic focus into high-voltage power semiconductors for AI computing and electric vehicles.
Value
$4.12M
Counterparty
Hexa Creation Inc.
“This acquisition marks XMax’s entry into high-voltage power semiconductors, a field closely tied to the growing power demands of AI infrastructure. The acquisition of Hexa Creation diversifies our business opportunities and complements XMax’s growing AI business as XMax builds out AI software, platform-based and GPU services through our wholly owned subsidiaries XMax AI Inc. and Elonx AI Holdings PTE. LTD.”
Andy Lu, Chief Executive Officer of XMax
“We believe the acquisition by XMax would give our 1200V vertical GaN work a path toward commercialization. We believe vertical GaN can bring higher efficiency and power density to high-voltage applications, and XMax’s support allows us to focus on advancing that technology.”
Professor Yuji Zhao, CEO and Founder of Hexa Creation
Hepion Pharmaceuticals Signs $4.38M M&A Deal with Gravitas Life Sciences, LLC
Hepion Pharmaceuticals completed the acquisition of all issued and outstanding membership interests of Gravitas Life Sciences, LLC from Gravitas Collective Corp. The total consideration consisted of $2.0 million in cash, 25,000,000 shares of common stock valued at $2.25 million, and an additional $135,000 payment. The transaction is classified as a related party transaction as several Hepion directors are also officers of Gravitas Life Sciences.
Alpine Income Property Trust Signs $117M M&A Deal with institutional owner
Alpine Income Property Trust, Inc. entered into a definitive agreement to acquire a 13-property industrial portfolio across 11 states for $117.3 million. The company has made a $1.0 million non-refundable earnest money deposit and expects the closing of the acquisition to be probable.
Alaunos Therapeutics received a delisting notice from Nasdaq on October 5, 2026, for failing to maintain the minimum $2.5 million stockholders' equity requirement. The company intends to request a hearing before the Nasdaq Hearings Panel to stay the delisting and is currently evaluating strategic alternatives to regain compliance.
Ashford Hospitality Trust Divestiture to SSN 9000 Bartram Road LLC for $26M
Ashford Hospitality Trust completed the sale of the 263-room Embassy Suites Philadelphia Airport hotel for approximately $26.0 million in cash. The company utilized approximately $24.6 million of the proceeds to pay down a mortgage loan secured by a 12-hotel portfolio. This transaction is part of the company's ongoing strategy to dispose of assets and reduce its outstanding indebtedness.
Evernorth Holdings M&A Deal with Pathfinder Digital Assets LLC
Evernorth Holdings Inc. (Pubco) completed its previously announced business combination with Pathfinder Digital Assets LLC, Ripple Labs Inc., and Arrington Capital SPAC I Inc. on October 9, 2026. In connection with the closing, SPAC shareholders redeemed approximately 18.46 million shares for $195.39 million in cash, representing 80.3% of eligible shares.
Better Home & Finance Holding Nasdaq/NYSE Compliance Notice
Better Home & Finance Holding Company received a deficiency notice from Nasdaq on October 8, 2026, for failing to meet multiple corporate governance requirements following recent board resignations. The company is currently non-compliant with rules requiring a majority of independent directors and independent oversight for its audit, compensation, and nominating committees. The company has 45 days to submit a plan to regain compliance, and the notice has no immediate effect on the listing of its Class A common stock (BETR).
Accendra Health received a deficiency notice from the NYSE on October 6, 2026, because its common stock average closing price fell below $1.00 over a 30 trading-day period. The company has six months to regain compliance and is considering alternatives including a potential reverse stock split. The notice does not immediately impact the listing or the company's business operations.
Baldwin Insurance Group M&A Deal with Cobbs Allen Capital Holdings, LLC
The Baldwin Insurance Group, Inc. is filing audited financial statements and pro forma financial information related to its previously completed acquisition of Cobbs Allen Capital Holdings, LLC. The transaction was consummated on January 1, 2026, and this filing serves as a required financial update to the original merger disclosure.
Pebblebrook Hotel Trust completed the sale of The Hotel Zags, a 174-room property in Portland, Oregon, for $10.0 million to an undisclosed third party. The hotel had been operating at an estimated trailing twelve-month net loss of $0.8 million. The company intends to use the proceeds for general corporate purposes, including potential share repurchases.
Cheetah Net Supply Chain Service Inc. entered into a securities purchase agreement with its CEO, Huan Liu, to sell 100,000 shares of Class B common stock in a private placement. The transaction generated gross proceeds of $330,000 at a purchase price of $3.30 per share. The sale was conducted as an unregistered sale of equity securities exempt from registration under Regulation S or Section 4(a)(2).
Mangoceuticals, Inc. entered into a securities purchase agreement for a registered direct offering of 657,000 shares of common stock and accompanying warrants to purchase up to 657,000 additional shares. The offering was priced at $0.75 per unit, representing a 74% premium to the recent market close, and is expected to generate gross proceeds of approximately $492,750 for working capital and general corporate purposes.
Bank7 M&A Deal with Century Financial Services Corporation
Bank7 Corp. provided a status update on its pending acquisition of Century Financial Services Corporation, noting that Century shareholders have approved the merger. The company has also received necessary regulatory approvals from the Federal Reserve and the New Mexico Financial Institutions Division, with the deal expected to close around November 1, 2026.
Profound Medical Partnership with Telix Pharmaceuticals Limited
Profound Medical Corp. entered into a co-education agreement with Telix Pharmaceuticals to advance PSMA-informed prostate care. The collaboration aims to educate physicians on the complementary roles of Telix’s PSMA-PET molecular imaging technologies and Profound’s MRI-guided TULSA-PRO platform. The partnership is intended to increase physician awareness, support patient selection, and expand access to the TULSA Procedure.
Villa Magna, LLC acquired a controlling interest in Metrospaces, Inc. from GBS Capital Partners and Oscar Brito through the purchase of Series B and Series E Preferred Stock. The transaction represents a change in control, with the buyer acquiring approximately 72% of the total voting power. As part of the agreement, the buyer committed to funding an OTC Markets application and a reverse stock split corporate-action package within 120 days.
Quanome Technologies' subsidiary XDT Infrastructure I, LLC secured its first enterprise customer agreement for dedicated AI inference services. The 60-month contract has a total commitment value exceeding $100 million, with service expected to commence within approximately two months.
IT Tech Packaging received an extension from NYSE Regulation to regain compliance with continued listing standards after failing to timely file its 2025 Annual Report and subsequent 2026 Quarterly Reports. The company has been granted a plan period until April 15, 2027, to complete the delayed filings and avoid potential delisting proceedings.
Pilgrim’s Pride Corporation has formed a special committee of independent directors to evaluate an unsolicited proposal from JBS N.V. to acquire all remaining outstanding shares of the company. The committee has appointed Ropes & Gray LLP and Moelis & Company LLC as advisors to review the potential take-private transaction, which would require a majority vote from minority shareholders.
TruGolf Holdings Signs $140M M&A Deal with Polymath Research Inc.
TruGolf Holdings, Inc. completed the acquisition of Polymath Research Inc. through an amalgamation with a Canadian subsidiary. The transaction was valued at a $140 million reference amount, with Polymath shareholders receiving a combination of Class A common stock and newly designated Series C convertible preferred stock.
Iron Horse Acquisition II M&A Deal with Electra Vehicles, Inc.
Iron Horse Acquisition II Corp. (IRHO) provided an updated investor presentation regarding its previously announced business combination with Electra Vehicles, Inc. Electra specializes in AI-powered battery intelligence solutions for electric vehicles, energy storage systems, and AI infrastructure. The filing serves as a status update for the pending merger, which will be submitted for shareholder approval via a registration statement on Form S-4.